What to expect

Before starting treatment, it’s important that you and your doctor work together to ensure that ARIKAYCE fits in with your needs and lifestyle. When you talk with your doctor about your goals, it can help you better understand how you can track your progress as well as when you may start to see results.

Here's how to get started

Talk to your doctor about how long you will be on ARIKAYCE

Knowing how long you can expect to be on ARIKAYCE can help you feel prepared. You may stay on treatment until you have tested MAC-negative. However, even after you test MAC-negative, your doctor may decide to keep you on treatment longer. This is to help prevent the MAC infection from coming back.

In the study, for instance, people continued ARIKAYCE treatment for 12 months after testing negative.

Make a plan for fitting ARIKAYCE into your routine

Know how, when, and where to fit ARIKAYCE treatment into your daily life.

  • Determine when to take treatment. Taking your medication at the same time of day can help it become part of your routine
  • Find your treatment space. Look for a peaceful environment: a comfy chair or a seat by the window. You'll also want a clean, flat surface near a power outlet
  • Catch up on TV, your favorite podcast, or audiobook—something you enjoy. Remember: it will need to be an activity that is hands-free and allows you to sit upright to ensure proper nebulizing

Keep track of any side effects you experience, and ask your doctor about ways you can try to help manage them

Part of your treatment plan is understanding and managing side effects. When you have a plan for dealing with side effects, you have a better chance of taking treatment as prescribed and testing negative.

If you do experience any side effects while taking ARIKAYCE, be sure to talk to your doctor.

Use this worksheet to help create a treatment plan with your doctor

Being prepared for possible side effects

Doctor Discussion

Everyone responds to treatment differently. If you have questions about the possible side effects associated with ARIKAYCE, be sure to speak with your doctor

ARIKAYCE can cause serious side effects, such as:

  • allergic inflammation of the lungs. These respiratory problems may be symptoms of allergic inflammation of the lungs and often come with:

    • fever
    • coughing
    • fast breathing
    • wheezing
    • shortness of breath
  • coughing up of blood (hemoptysis). Coughing up blood is a serious and common side effect of ARIKAYCE
  • severe breathing problems. Severe breathing problems can be symptoms of bronchospasm. Bronchospasm is a serious and common side effect of ARIKAYCE. Bronchospasm symptoms include:

    • shortness of breath
    • wheezing
    • difficult or labored breathing
    • coughing or chest tightness
  • worsening of chronic obstructive pulmonary disease (COPD). This is a serious and common side effect of ARIKAYCE

  • serious allergic reactions. Serious allergic reactions that may lead to death have happened to people who take ARIKAYCE. Stop taking ARIKAYCE right away and get emergency medical help if you have any of the following symptoms of a serious allergic reaction: hives, itching, redness or blushing of the skin (flushing), swollen lips, tongue or throat, trouble breathing or wheezing, shortness of breath, noisy high-pitched breathing (stridor), cough, nausea, vomiting, diarrhea, feel cramps in your stomach area, fast heart rate, feeling light headed, feeling faint, loss of control of the bowels or bladder (incontinence), and dizziness

While using ARIKAYCE, these side effects may become serious enough that treatment in a hospital is needed.

ARIKAYCE may cause serious side effects, including:

  • hearing loss or ringing in the ears (ototoxicity). Ototoxicity is a serious and common side effect of ARIKAYCE. Tell your healthcare provider right away if you have hearing loss or you hear noises in your ears, such as ringing or hissing. Tell your healthcare provider if you start having problems with balance or dizziness (vertigo)
  • worsening kidney problems (nephrotoxicity). ARIKAYCE is in a class of medicines which may cause worsening kidney problems. Your healthcare provider may do a blood test to check how well your kidneys are working during your treatment with ARIKAYCE
  • worsening muscle weakness (neuromuscular blockade). ARIKAYCE is in a class of medicines which can cause muscle weakness to get worse in people who already have problems with muscle weakness (myasthenia gravis)
20.2% of patients taking ARIKAYCE had side effects and 16.1% of patients taking combination therapy alone had side effects

In the clinical study, 19.7% of people taking ARIKAYCE + multidrug regimen experienced serious side effects compared to 16.1% of people taking a multidrug regimen alone

The most common side effects of ARIKAYCE are:

  • changes in voice and hoarseness (dysphonia)
  • cough during or after a dose of ARIKAYCE
  • muscle pain
  • sore throat
  • tiredness (fatigue)
  • diarrhea
  • nausea
  • headache
  • fever
  • decreased weight
  • vomiting
  • rash
  • increased sputum
  • chest discomfort

Cough during or after a dose of ARIKAYCE was reported most often during the first month of treatment

81%

Most people who experienced side effects did not stop treatment

In the clinical study, 81% (182/224) of people taking ARIKAYCE + multidrug regimen did not stop treatment even though they had at least one side effect

If you experience any side effects while taking ARIKAYCE, be sure to talk to your doctor about them

These are not all of the possible side effects of ARIKAYCE. Call your doctor or pharmacist for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 (1-800-332-1088).

Tell your healthcare provider about all the medicines you take, including prescription medicines and over-the-counter medicines, vitamins, and herbal supplements. Keep a list of the medicines you take and show your doctor and pharmacist when you get a new medicine.

Managing potential side effects along your ARIKAYCE treatment journey

A recent survey reported potential techniques and strategies to help manage certain respiratory-related side effects when taking ARIKAYCE.

The survey was conducted via telephone with 26 people prescribed ARIKAYCE during a 2-month period at 2 academic medical centers in the United States.

Survey disclosures

  • This information is not included in the ARIKAYCE full Prescribing Information
  • Writing assistance was provided to the authors through funding from Insmed Incorporated
  • Insmed was not involved with the conceptualization, development, conduct, or analyses of the study

Below are potential management strategies used in the survey for certain side effects. Always talk to your doctor before starting any management techniques.

SWIPE TO SEE MORE
Management strategy
Increased coughing
Changes in voice and hoarseness (dysphonia)
Shortness of breath (dyspnea)
Increased sputum production
Lozenges
Soothing fluid intake
Warm water or glycerin gargle post dosing
Limiting physical activity
Changing ARIKAYCE administration to evening
Brief interruptions of ARIKAYCE
Bronchodilator use (medicine that increases airflow to the lungs)
Antitussive agents (cough medicine)
Increased supplemental oxygen, if already administering
Airway clearance* (eg, specific breathing techniques, chest percussion, and positive expiratory pressure therapy)
Management strategy
Increased coughing
Changes in voice and hoarseness (dysphonia)
Shortness of breath (dyspnea)
Increased sputum production
Lozenges
Soothing fluid intake
Warm water or glycerin gargle post dosing
Limiting physical activity
Changing ARIKAYCE administration to evening
Brief interruptions of ARIKAYCE
Bronchodilator use (medicine that increases airflow to the lungs)
Antitussive agents (cough medicine)
Increased supplemental oxygen, if already administering
Airway clearance* (eg, specific breathing techniques, chest percussion, and positive expiratory pressure therapy)

Increased sputum production may be a form of airway clearance in itself.

Remember, management strategies should be discussed with your doctor, as they may vary by person.

Find sample questions to help you start a conversation about ARIKAYCE with your doctor by downloading this

Next, learn about taking ARIKAYCE by watching the device video
Back to Top
IMPORTANT SAFETY INFORMATION AND INDICATION ARIKAYCE is associated with: risk of increased respiratory adverse reactions including allergic inflammation of lungs, coughing up blood, severe breathing problems and worsening of COPD.

ARIKAYCE can cause serious side effects, including:

  • allergic inflammation of the lungs. These respiratory problems may be symptoms of allergic inflammation of the lungs and often come with fever, wheezing, coughing, shortness of breath, and fast breathing
  • coughing up of blood (hemoptysis). Coughing up blood is a serious and common side effect of ARIKAYCE
  • severe breathing problems. Severe breathing problems can be symptoms of bronchospasm. Bronchospasm is a serious and common side effect of ARIKAYCE. Bronchospasm symptoms include shortness of breath, difficult or labored breathing, wheezing, and coughing or chest tightness
  • worsening of chronic obstructive pulmonary disease (COPD). This is a serious and common side effect of ARIKAYCE
  • serious allergic reactions. Serious allergic reactions that may lead to death have happened to people who take ARIKAYCE. Stop taking ARIKAYCE right away and get emergency medical help if you have any of the following symptoms of a serious allergic reaction: hives, itching, redness or blushing of the skin (flushing), swollen lips, tongue or throat, trouble breathing or wheezing, shortness of breath, noisy high-pitched breathing (stridor), cough, nausea, vomiting, diarrhea, feel cramps in your stomach area, fast heart rate, feeling light headed, feeling faint, loss of control of the bowels or bladder (incontinence), and dizziness

While using ARIKAYCE, these side effects may become serious enough that treatment in a hospital is needed. Call your healthcare provider or get medical help right away if you have any of these serious side effects while taking ARIKAYCE. Your healthcare provider may ask you to stop using ARIKAYCE for a short period of time or completely stop using ARIKAYCE.

Do not use ARIKAYCE if you are allergic to any aminoglycoside, or any of the ingredients in ARIKAYCE.

Before using ARIKAYCE, tell your healthcare provider about all medical conditions, including if you:

  • have asthma, COPD, shortness of breath, or wheezing (bronchospasm)
  • have been told you have poor lung function
  • have hearing problems, such as ringing in your ears or hearing loss
  • have dizziness or a sense of the room spinning
  • have kidney problems
  • have neuromuscular disease, such as myasthenia gravis
  • are pregnant or plan to become pregnant. It is not known if ARIKAYCE can harm your unborn baby. ARIKAYCE is in a class of medicines that may be connected with complete deafness in babies at birth. The deafness affects both ears and cannot be changed
  • are breastfeeding or plan to breastfeed. It is not known if the medicine in ARIKAYCE passes into your breast milk and if it can harm your baby. Talk to your healthcare provider about the best way to feed your baby during treatment with ARIKAYCE

Tell your healthcare provider about all the medicines you take, including prescription medicines and over-the-counter medicines, vitamins, and herbal supplements.

ARIKAYCE may cause serious side effects, including:

  • hearing loss or ringing in the ears (ototoxicity). Ototoxicity is a serious and common side effect of ARIKAYCE. Tell your healthcare provider right away if you have hearing loss or you hear noises in your ears, such as ringing or hissing. Tell your healthcare provider if you start having problems with balance or dizziness (vertigo)
  • worsening kidney problems (nephrotoxicity). ARIKAYCE is in a class of medicines which may cause worsening kidney problems. Your healthcare provider may do a blood test to check how well your kidneys are working during your treatment with ARIKAYCE
  • worsening muscle weakness (neuromuscular blockade). ARIKAYCE is in a class of medicines which can cause muscle weakness to get worse in people who already have problems with muscle weakness (myasthenia gravis)

The most common side effects of ARIKAYCE include: changes in voice and hoarseness (dysphonia), cough during or after a dose of ARIKAYCE, especially in the first month after starting treatment, muscle pain, sore throat, tiredness (fatigue), diarrhea, nausea, headache, fever, decreased weight, vomiting, rash, increased sputum, or chest discomfort.

These are not all of the possible side effects of ARIKAYCE. Call your doctor or pharmacist for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

What is ARIKAYCE?

ARIKAYCE is a prescription medicine used to treat adults with refractory (difficult to treat) Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug treatment plan (regimen).

It is not known if ARIKAYCE is safe and effective in children younger than 18 years of age.

This product was approved by FDA using the Limited Population pathway. This means FDA has approved this drug for a limited and specific patient population, and studies on the drug may have only answered focused questions about its safety and effectiveness.

Make sure we have your correct address!

If the suggested address looks correct, select it and click SUBMIT. To edit your address, click BACK.

Sign up

< Back